Ieq Capital, LLC Alkermes Plc. Put Options Transaction History
Ieq Capital, LLC
- $10.1 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ALKS
# of Institutions
376Shares Held
173MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$979 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$622 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$412 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$296 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$254 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.52B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...